Segall Bryant & Hamill LLC Purchases 10,065 Shares of Utah Medical Products, Inc. $UTMD

Segall Bryant & Hamill LLC grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 87.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,547 shares of the medical instruments supplier’s stock after acquiring an additional 10,065 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Utah Medical Products were worth $1,336,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Comerica Bank boosted its position in shares of Utah Medical Products by 435.6% during the 3rd quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 440 shares in the last quarter. Fifth Third Bancorp acquired a new position in shares of Utah Medical Products in the 1st quarter worth approximately $43,000. BNP Paribas Financial Markets boosted its stake in Utah Medical Products by 89.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock valued at $67,000 after buying an additional 501 shares in the last quarter. State of Wyoming bought a new stake in Utah Medical Products in the second quarter valued at $132,000. Finally, Advisory Services Network LLC bought a new position in shares of Utah Medical Products during the third quarter valued at $159,000. Institutional investors and hedge funds own 69.60% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Utah Medical Products Stock Down 1.5%

Shares of NASDAQ:UTMD opened at $71.21 on Thursday. Utah Medical Products, Inc. has a 12 month low of $53.66 and a 12 month high of $75.75. The company’s 50-day moving average price is $68.88 and its two-hundred day moving average price is $66.10. The firm has a market cap of $226.73 million, a P/E ratio of 21.71 and a beta of 0.35.

Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share for the quarter. The company had revenue of $8.53 million during the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, October 5th. Stockholders of record on Thursday, September 17th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Thursday, September 17th. Utah Medical Products’s dividend payout ratio is 37.80%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).